Summary of Public Response and Regulatory Perspective
Summary of Public Response and Regulatory Perspective. Katherine Laessig, M.D. Division of Antiviral Drug Products January 11, 2001. Presentation Outline. Defining terms Summary of responses re: study components (pt. pop’n, study regimen, endpoints, duration
386 views • 30 slides